{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:12:39Z","timestamp":1789776759144,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Adult-onset Still\u2019s disease (AOSD) is a rare systemic inflammatory disorder. Diagnosing AOSD can be challenging, as disease presentation and clinical course are highly heterogeneous. For unclear reasons, a few patients develop life-threatening complications. Our objective was to determine whether these cases resulted from therapeutic delay or could represent a peculiar AOSD subset.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a multicentre retrospective study of 20 AOSD patients with organ failure requiring intensive care unit admission and 41 control AOSD patients without organ failure. Clinico-biological data at hospital admission were explored using supervised analyses and unsupervised dimension reduction analysis (factor analysis of mixed data, FAMD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Disease duration before admission was shorter in patients with life-threatening AOSD (median, 10 vs 20 days, <jats:italic>p<\/jats:italic> = 0.007). Disease duration before AOSD therapy initiation also tended to be shorter (median, 24 vs 32 days, <jats:italic>p<\/jats:italic> = 0.068). Despite this shorter disease duration, FAMD, hierarchical clustering and univariate analyses showed that these patients exhibited distinctive characteristics at first presentation, including younger age; higher frequency of splenomegaly, liver, cardiac and\/or lung involvement; less frequent arthralgia; and higher ferritin level. In multivariate analysis, 3 parameters predicted life-threatening complications: lack of arthralgia, younger age and shorter time between fever onset and hospitalisation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study suggests that life-threatening complications of AOSD occur very early, in a peculiar subset, which we propose to name catastrophic adult-onset Still\u2019s disease (CAOSD). Its exact burden may be underestimated and remains to be clarified through large multicentre cohorts. Further studies are needed to identify red flags and define the optimal therapeutic strategy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-021-02631-7","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T04:02:39Z","timestamp":1633924959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Catastrophic adult-onset Still\u2019s disease as a distinct life-threatening clinical subset: case\u2013control study with dimension reduction analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Ana\u00efs","family":"Wahbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Tessoulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Bretonni\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doroth\u00e9e","family":"Carpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Decaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Fardet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Geri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Godmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Goujard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Maisonneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Pouchot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Ziza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Georgin-Lavialle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hamidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7707-5794","authenticated-orcid":false,"given":"Antoine","family":"N\u00e9el","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"key":"2631_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","volume":"14","author":"E Feist","year":"2018","unstructured":"Feist E, Mitrovic S, Fautrel B. Mechanisms, biomarkers and targets for adult-onset Still\u2019s disease. Nat Rev Rheumatol. 2018;14:603\u201318.","journal-title":"Nat Rev Rheumatol."},{"key":"2631_CR2","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still\u2019s disease. J Rheumatol. 1992;19:424\u201330.","journal-title":"J Rheumatol."},{"key":"2631_CR3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","volume":"81","author":"B Fautrel","year":"2002","unstructured":"Fautrel B, Zing E, Golmard JL, Le Moel G, Bissery A, Rioux C, et al. Medicine (Baltimore). 2002;81:194\u2013200.","journal-title":"Medicine (Baltimore)."},{"key":"2631_CR4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/ard.2003.012484","volume":"63","author":"MA Hamidou","year":"2004","unstructured":"Hamidou MA, Denis M, Barbarot S, Boutoille D, Belizna C, Le Mo\u00ebl G. Usefulness of glycosylated ferritin in atypical presentations of adult onset Still\u2019s disease. Ann Rheum Dis. 2004;63:605.","journal-title":"Ann Rheum Dis."},{"key":"2631_CR5","first-page":"1055","volume":"61","author":"JM Wouters","year":"1986","unstructured":"Wouters JM, van de Putte LB. Adult-onset Still\u2019s disease; clinical and laboratory features, treatment and progress of 45 cases. Q J Med. 1986;61:1055\u201365.","journal-title":"Q J Med."},{"key":"2631_CR6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","volume":"70","author":"J Pouchot","year":"1991","unstructured":"Pouchot J, Sampalis JS, Beaudet F, Carette S, D\u00e9cary F, Salusinsky-Sternbach M, et al. Adult Still\u2019s disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore). 1991;70:118\u201336.","journal-title":"Medicine (Baltimore)."},{"key":"2631_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/MD.0000000000000021","volume":"93","author":"M Gerfaud-Valentin","year":"2014","unstructured":"Gerfaud-Valentin M, Maucort-Boulch D, Hot A, Iwaz J, Ninet J, Durieu I, et al. Adult-onset Still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients. Medicine (Baltimore). 2014;93:91\u20139.","journal-title":"Medicine (Baltimore)."},{"key":"2631_CR8","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1002\/art.27532","volume":"62","author":"S Franchini","year":"2010","unstructured":"Franchini S, Dagna L, Salvo F, Aiello P, Baldissera E, Sabbadini MG. Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still\u2019s disease. Arthritis Rheum. 2010;62:2530\u20135.","journal-title":"Arthritis Rheum."},{"key":"2631_CR9","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3899\/jrheum.161286","volume":"44","author":"SS Ahn","year":"2017","unstructured":"Ahn SS, Yoo B-W, Jung SM, Lee SW, Park YB, Song JJ. Application of the 2016 EULAR\/ACR\/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset Still disease. J Rheumatol. 2017;44:996\u20131003.","journal-title":"J Rheumatol."},{"key":"2631_CR10","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3899\/jrheum.170955","volume":"45","author":"P Ruscitti","year":"2018","unstructured":"Ruscitti P, Iacono D, Ciccia F, Emmi G, Cipriani P, Grembiale RD, et al. Macrophage activation syndrome in patients affected by adult-onset Still disease: analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort. J Rheumatol. 2018;45:864\u201372.","journal-title":"J Rheumatol."},{"key":"2631_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13054-018-2012-2","volume":"22","author":"A N\u00e9el","year":"2018","unstructured":"N\u00e9el A, Wahbi A, Tessoulin B, Boileau J, Carpentier D, Decaux O, et al. Diagnostic and management of life-threatening adult-onset Still disease: a French nationwide multicenter study and systematic literature review. Crit Care. 2018;22:88.","journal-title":"Crit Care."},{"key":"2631_CR12","doi-asserted-by":"publisher","DOI":"10.1201\/b17700","volume-title":"Multiple factor analysis by example using R. 1st ed","author":"J Pag\u00e8s","year":"2014","unstructured":"Pag\u00e8s J. Multiple factor analysis by example using R. 1st ed. Boca Raton: Chapman and Hall\/CRC Press; 2014. https:\/\/doi.org\/10.1201\/b17700."},{"key":"2631_CR13","unstructured":"missMDA: a package for handling missing values in multivariate data analysis | Josse | Journal of Statistical Software. [cited 2017 Sep 23]; Available from: https:\/\/www.jstatsoft.org\/article\/view\/v070i01"},{"issue":"1","key":"2631_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v025.i01","volume":"25","author":"S L\u00ea","year":"2008","unstructured":"L\u00ea S, Josse J, Husson F. FactoMineR: an R package for multivariate analysis. J Stat Softw. 2008;25(1):1\u201318.","journal-title":"J Stat Softw."},{"issue":"1","key":"2631_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v070.i01","volume":"70","author":"J Josse","year":"2016","unstructured":"Josse J, Husson F. missMDA: a package for handling missing values in multivariate data analysis. J Stat Softw. 2016;70(1):1\u201331.","journal-title":"J Stat Softw."},{"key":"2631_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/ard.30.2.121","volume":"30","author":"EG Bywaters","year":"1971","unstructured":"Bywaters EG. Still\u2019s disease in the adult. Ann Rheum Dis. 1971;30:121\u201333.","journal-title":"Ann Rheum Dis."},{"key":"2631_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10067-014-2487-4","volume":"33","author":"P Efthimiou","year":"2014","unstructured":"Efthimiou P, Kadavath S, Mehta B. Life-threatening complications of adult-onset Still\u2019s disease. Clin Rheumatol. 2014;33:305\u201314.","journal-title":"Clin Rheumatol."},{"key":"2631_CR18","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/ard.2005.042143","volume":"65","author":"P Efthimiou","year":"2006","unstructured":"Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult onset Still\u2019s disease. Ann Rheum Dis. 2006;65:564\u201372.","journal-title":"Ann Rheum Dis."},{"key":"2631_CR19","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.semarthrit.2015.11.002","volume":"45","author":"A Lenert","year":"2016","unstructured":"Lenert A, Yao Q. Macrophage activation syndrome complicating adult onset Still\u2019s disease: a single center case series and comparison with literature. Semin Arthritis Rheum. 2016;45:711\u20136.","journal-title":"Semin Arthritis Rheum."},{"key":"2631_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/MD.0b013e3181caf100","volume":"89","author":"A Hot","year":"2010","unstructured":"Hot A, Toh ML, Copp\u00e9r\u00e9 B, Perard L, Madoux MH, Mausservey C, et al. Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long-term outcome: a case-control study of 8 patients. Medicine (Baltimore). 2010;89:37\u201346.","journal-title":"Medicine (Baltimore)."},{"key":"2631_CR21","doi-asserted-by":"publisher","first-page":"e451","DOI":"10.1097\/MD.0000000000000451","volume":"94","author":"CB Bae","year":"2015","unstructured":"Bae CB, Jung JY, Kim HA, Suh CH. Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patients. Medicine (Baltimore). 2015;94:e451.","journal-title":"Medicine (Baltimore)"},{"key":"2631_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s12026-014-8561-9","volume":"61","author":"Y Jamilloux","year":"2015","unstructured":"Jamilloux Y, Gerfaud-Valentin M, Martinon F, Belot A, Henry T, S\u00e8ve P. Pathogenesis of adult-onset Still\u2019s disease: new insights from the juvenile counterpart. Immunol Res. 2015;61:53\u201362.","journal-title":"Immunol Res."},{"key":"2631_CR23","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1586\/1744666X.2015.1037287","volume":"11","author":"S Colafrancesco","year":"2015","unstructured":"Colafrancesco S, Priori R, Valesini G. Presentation and diagnosis of adult-onset Still\u2019s disease: the implications of current and emerging markers in overcoming the diagnostic challenge. Expert Rev Clin Immunol. 2015;11:749\u201361.","journal-title":"Expert Rev Clin Immunol."},{"key":"2631_CR24","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/art.23437","volume":"58","author":"M Gattorno","year":"2008","unstructured":"Gattorno M, Piccini A, Lasigli\u00e8 D, Tassi S, Brisca G, Carta S, et al. The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2008;58:1505\u201315.","journal-title":"Arthritis Rheum."},{"key":"2631_CR25","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/acr.22194","volume":"66","author":"H Ichida","year":"2014","unstructured":"Ichida H, Kawaguchi Y, Sugiura T, Takagi K, Katsumata Y, Gono T, et al. Clinical manifestations of Adult-onset Still\u2019s disease presenting with erosive arthritis: association with low levels of ferritin and Interleukin-18. Arthritis Care Res. 2014;66:642\u20136.","journal-title":"Arthritis Care Res."},{"key":"2631_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cyto.2012.11.025","volume":"61","author":"M Shimizu","year":"2013","unstructured":"Shimizu M, Nakagishi Y, Yachie A. Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles. Cytokine. 2013;61:345\u20138.","journal-title":"Cytokine."},{"key":"2631_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.clim.2016.05.010","volume":"169","author":"N Inoue","year":"2016","unstructured":"Inoue N, Shimizu M, Tsunoda S, Kawano M, Matsumura M, Yachie A. Cytokine profile in adult-onset Still\u2019s disease: comparison with systemic juvenile idiopathic arthritis. Clin Immunol. 2016;169:8\u201313.","journal-title":"Clin Immunol."},{"key":"2631_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13075-019-1838-6","volume":"21","author":"F Vercruysse","year":"2019","unstructured":"Vercruysse F, Barnetche T, Lazaro E, Shipley E, Lifermann F, Balageas A, et al. Adult-onset Still\u2019s disease biological treatment strategy may depend on the phenotypic dichotomy. Arthritis Res Ther. 2019;21:53.","journal-title":"Arthritis Res Ther."},{"key":"2631_CR29","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s10067-016-3308-8","volume":"35","author":"P Sfriso","year":"2016","unstructured":"Sfriso P, Priori R, Valesini G, Rossi S, Montecucco CM, D\u2019Ascanio A, et al. Adult-onset Still\u2019s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients. Clin Rheumatol. 2016;35:1683\u20139.","journal-title":"Clin Rheumatol."},{"key":"2631_CR30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3109\/14397595.2014.974881","volume":"25","author":"YF Asanuma","year":"2015","unstructured":"Asanuma YF, Mimura T, Tsuboi H, Noma H, Miyoshi F, Yamamoto K, et al. Nationwide epidemiological survey of 169 patients with adult Still\u2019s disease in Japan. Mod Rheumatol. 2015;25:393\u2013400.","journal-title":"Mod Rheumatol."},{"key":"2631_CR31","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood.2018894618","volume":"133","author":"P La Ros\u00e9e","year":"2019","unstructured":"La Ros\u00e9e P, Horne A, Hines M, von Bahr GT, Machowicz R, Berliner N, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133:2465\u201377.","journal-title":"Blood."},{"key":"2631_CR32","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1080\/1744666X.2017.1375853","volume":"13","author":"P Ruscitti","year":"2017","unstructured":"Ruscitti P, Ursini F, Cipriani P, De Sarro G, Giacomelli R. Biologic drugs in adult onset Still\u2019s disease: a systematic review and meta-analysis of observational studies. Expert Rev Clin Immunol. 2017;13:1089\u201397.","journal-title":"Expert Rev Clin Immunol."},{"key":"2631_CR33","first-page":"840","volume":"77","author":"C Gabay","year":"2018","unstructured":"Gabay C, Fautrel B, Rech J, Spertini F, Feist E, K\u00f6tter I, et al. Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still\u2019s disease. Ann Rheum Dis. 2018;77:840\u20137.","journal-title":"Ann Rheum Dis."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-021-02631-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-021-02631-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-021-02631-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T16:20:01Z","timestamp":1633969201000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-021-02631-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2631"],"URL":"https:\/\/doi.org\/10.1186\/s13075-021-02631-7","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,11]]},"assertion":[{"value":"8 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This observational study was performed in accordance with the Declaration of Helsinki, European Union and French ethical regulations (reference methodology MR003: retrospective study of anonymised data with ethics approval waiver).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"256"}}